Nymox Pharmaceutical Corp (NYMX) Stock
NYMX is no longer traded. Nymox Pharmaceutical was delisted from the Nasdaq in September 2023.
Prices on this page are historical; the last trade was September 7, 2023 at $0.47.
Nymox Pharmaceutical stock price history
NYMX final trading statistics
- Final close
- $0.47
- Final trading day
- Sep 7, 2023
- Market cap at delisting
- $18.25M
- Shares outstanding
- 91.27M
- Final 52-week range
- $0.12 – $1.15
- Avg. volume (final 3 mo.)
- 193,048
- All-time high (split-adj.)
- $12.75 · Mar 1998
- All-time low (split-adj.)
- $0.19 · Jun 2023
- Return since IPO
- -96.1%
- Beta
- 0.65
- Book value / share
- -$0.02
- Price / book
- -23.38
Nymox Pharmaceutical annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$6.6M | -$0.08 |
| FY2021 | $0.00 | -$12.6M | -$0.15 |
| FY2020 | $5.0K | -$11.8M | -$0.17 |
| FY2019 | $116.0K | -$13.2M | -$0.20 |
| FY2018 | $299.0K | -$10.6M | -$0.18 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.
Nymox Pharmaceutical stock FAQ
What happened to Nymox Pharmaceutical stock?
Nymox Pharmaceutical stock was delisted from the Nasdaq. Its final close was $0.47 on September 7, 2023.
Is NYMX stock still trading?
No. NYMX was delisted from the Nasdaq in September 2023 and no longer trades on a U.S. exchange.
What was the last price of NYMX stock?
NYMX closed at $0.47 on its final trading day, September 7, 2023, for a market value of about $18.25M.
What were Nymox Pharmaceutical's revenue and earnings in its last full fiscal year?
Nymox Pharmaceutical reported revenue of $0.00 and net income of -$6.6M in fiscal 2022, its last full year as a public company.
When did Nymox Pharmaceutical go public?
Nymox Pharmaceutical Corp stock began trading on December 1, 1997.